{"DataElement":{"publicId":"3371435","version":"1","preferredName":"Thyroid Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical Tumor T Stage","preferredDefinition":"Extent of the primary thyroid tumor based on evidence obtained from clinical assessment parameters determined prior to treatment.","longName":"3366313v1.0:3371412v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3366313","version":"1","preferredName":"Thyroid Gland Neoplasm Clinical T Stage","preferredDefinition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"3366311v1.0:2207100v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3366311","version":"1","preferredName":"Thyroid Gland Neoplasm","preferredDefinition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12400:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland","conceptCode":"C12400","definition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B784C9DE-7AB2-3473-E040-BB89AD43638B","latestVersionIndicator":"Yes","beginDate":"2012-01-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-27","modifiedBy":"ONEDATA","dateModified":"2012-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B784C9DE-7AC0-3473-E040-BB89AD43638B","latestVersionIndicator":"Yes","beginDate":"2012-01-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3371412","version":"1","preferredName":"Thyroid Cancer American Joint Committee on Cancer (AJCC) Edition 7 T Stage","preferredDefinition":"A finding about one or more characteristics of thyroid cancer, following the rules of the TNM AJCC v7 classification system.  Both the histologic diagnosis and the age of the patient are of such importance in the behavior and prognosis of thyroid cancer that these factors are included in this staging system. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3371412v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4b","valueDescription":"Thyroid Cancer pT4b TNM Finding v7","ValueMeaning":{"publicId":"3180191","version":"1","preferredName":"Thyroid Cancer pT4b TNM Finding v7","longName":"3180191","preferredDefinition":"Thyroid cancer with very advanced disease.  Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pT4b TNM Finding v7","conceptCode":"C89152","definition":"Thyroid cancer with very advanced disease.  Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels.  (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F83A59-5C29-B9D2-E040-BB89AD430DD2","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8604700-0429-A634-E040-BB89AD436E9D","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Thyroid Cancer pT4a TNM Finding v7","ValueMeaning":{"publicId":"3180193","version":"1","preferredName":"Thyroid Cancer pT4a TNM Finding v7","longName":"3180193","preferredDefinition":"Thyroid cancer with moderately advanced local disease.  Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pT4a TNM Finding v7","conceptCode":"C89150","definition":"Thyroid cancer with moderately advanced local disease.  Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F83A59-5C4F-B9D2-E040-BB89AD430DD2","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8604700-043E-A634-E040-BB89AD436E9D","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"T3","valueDescription":"Thyroid Cancer pT3 TNM Finding","ValueMeaning":{"publicId":"3180197","version":"1","preferredName":"Thyroid Cancer pT3 TNM Finding","longName":"3180197","preferredDefinition":"Thyroid cancer with a tumor size greater than 4 cm in greatest dimension and limited to the thyroid gland, or a tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues).  (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pT3 TNM Finding v6 and v7","conceptCode":"C60864","definition":"Thyroid cancer with a tumor size greater than 4 cm in greatest dimension and limited to the thyroid gland, or a tumor of any size with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues).  (from AJCC 6th and 7th Eds.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F83A59-5C9B-B9D2-E040-BB89AD430DD2","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8604700-0453-A634-E040-BB89AD436E9D","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"T2","valueDescription":"Thyroid Cancer pT2 TNM Finding","ValueMeaning":{"publicId":"3180199","version":"1","preferredName":"Thyroid Cancer pT2 TNM Finding","longName":"3180199","preferredDefinition":"Thyroid cancer with a tumor size greater than 2 cm but not more than 4 cm in greatest dimension, and limited to the thyroid gland. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pT2 TNM Finding v6 and v7","conceptCode":"C60863","definition":"Thyroid cancer with a tumor size greater than 2 cm but not more than 4 cm in greatest dimension, and limited to the thyroid gland. (from AJCC 6th and 7th Eds.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F83A59-5CC1-B9D2-E040-BB89AD430DD2","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8604700-0468-A634-E040-BB89AD436E9D","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"T1b","valueDescription":"Thyroid Cancer pT1b TNM Finding v7","ValueMeaning":{"publicId":"3180201","version":"1","preferredName":"Thyroid Cancer pT1b TNM Finding v7","longName":"3180201","preferredDefinition":"Thyroid cancer with a tumor size of more than 1 cm but not more than 2 cm in greatest dimension, limited to the thyroid gland. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pT1b TNM Finding v7","conceptCode":"C89149","definition":"Thyroid cancer with a tumor size of more than 1 cm but not more than 2 cm in greatest dimension, limited to the thyroid gland. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F83A59-5CE7-B9D2-E040-BB89AD430DD2","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8604700-047D-A634-E040-BB89AD436E9D","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"T1a","valueDescription":"Thyroid Cancer pT1a TNM Finding v7","ValueMeaning":{"publicId":"3180203","version":"1","preferredName":"Thyroid Cancer pT1a TNM Finding v7","longName":"3180203","preferredDefinition":"Thyroid cancer with a tumor size of 1 cm or less in greatest dimension, limited to the thyroid gland. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pT1a TNM Finding v7","conceptCode":"C89148","definition":"Thyroid cancer with a tumor size of 1 cm or less in greatest dimension, limited to the thyroid gland. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F83A59-5D0D-B9D2-E040-BB89AD430DD2","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8604700-0492-A634-E040-BB89AD436E9D","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"T1","valueDescription":"Thyroid Cancer pT1 TNM Finding","ValueMeaning":{"publicId":"3180205","version":"1","preferredName":"Thyroid Cancer pT1 TNM Finding","longName":"3180205","preferredDefinition":"Thyroid cancer with a tumor size of 2 cm or less in greatest dimension, and limited to the thyroid gland. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pT1 TNM Finding v6 and v7","conceptCode":"C60862","definition":"Thyroid cancer with a tumor size of 2 cm or less in greatest dimension, and limited to the thyroid gland. (from AJCC 6th and 7th Eds.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F83A59-5D33-B9D2-E040-BB89AD430DD2","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8604700-04A7-A634-E040-BB89AD436E9D","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"T0","valueDescription":"Thyroid Cancer pT0 TNM Finding","ValueMeaning":{"publicId":"3180207","version":"1","preferredName":"Thyroid Cancer pT0 TNM Finding","longName":"3180207","preferredDefinition":"Thyroid cancer with no evidence of primary tumor. (from AJCC 6th and 7th Eds.).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pT0 TNM Finding v6 and v7","conceptCode":"C60861","definition":"Thyroid cancer with no evidence of primary tumor. (from AJCC 6th and 7th Eds.).","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98F83A59-5D59-B9D2-E040-BB89AD430DD2","latestVersionIndicator":"Yes","beginDate":"2011-01-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8604700-04BC-A634-E040-BB89AD436E9D","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"TX","valueDescription":"Thyroid Cancer pTX TNM Finding","ValueMeaning":{"publicId":"3178321","version":"1","preferredName":"Thyroid Cancer pTX TNM Finding","longName":"3178321","preferredDefinition":"Thyroid cancer in which the primary tumor cannot be assessed. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pTX TNM Finding v6 and v7","conceptCode":"C60860","definition":"Thyroid cancer in which the primary tumor cannot be assessed. (from AJCC 6th and 7th Eds.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98668D9A-EA8D-4F10-E040-BB89AD43093A","latestVersionIndicator":"Yes","beginDate":"2010-12-27","endDate":null,"createdBy":"BLABOLIJ","dateCreated":"2010-12-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8604700-04D1-A634-E040-BB89AD436E9D","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3371411","version":"1","preferredName":"Thyroid Cancer TNM Finding v7 American Joint Committee on Cancer T Stage Stage","preferredDefinition":"A finding about one or more characteristics of thyroid cancer, following the rules of the TNM AJCC v7 classification system.  Both the histologic diagnosis and the age of the patient are of such importance in the behavior and prognosis of thyroid cancer that these factors are included in this staging system. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89145:C39315:C25728:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer TNM Finding v7","conceptCode":"C89145","definition":"A finding about one or more characteristics of thyroid cancer, following the rules of the TNM AJCC v7 classification system.  Both the histologic diagnosis and the age of the patient are of such importance in the behavior and prognosis of thyroid cancer that these factors are included in this staging system. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8604700-03F6-A634-E040-BB89AD436E9D","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8604700-0407-A634-E040-BB89AD436E9D","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"COOPERM","dateModified":"2013-10-01","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3434443","version":"1","longName":"Thyroid","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000283","version":"1","longName":"Thyroid","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"THYROID_CLIN_T_STG","type":"COG GDE Short Name","context":"COG"}],"ReferenceDocuments":[{"name":"Clinical T Stage","type":"Preferred Question Text","description":"Clinical T Stage","url":null,"context":"NCI Standards"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"TNM Staging: Clinical T Stage","url":null,"context":"COG"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"B8606DF3-AD7E-79F6-E040-BB89AD433880","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}